Companies: 10,795·Total market cap: $144.5T
Orgenesis Inc.

Orgenesis Inc.

ORGSOTCHealthcare● Active
$0.50
+$0.01(+1.02%)
Market Cap$2558779
P/E Ratio
52W High$5.89
52W Low$0.02
Overview

Orgenesis Inc.(ORGS)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ORGS · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-2.80orgs eps ttm · orgs earnings per shareEarnings history
PE Ratio (TTM)orgs pe ratio ttm · orgs price to earningsPE Ratio deep dive
Revenue (TTM)$-12.9Morgs revenue ttm · orgs annual revenueFull revenue history
Dividend Yield不分红does orgs pay dividends · orgs dividend yieldDividend history
Shares Outstanding29.0Morgs shares outstanding · orgs floatShares outstanding history
Next EarningsAug 7, 2026Est.orgs earnings date · orgs next earningsEarnings history

财务快照

完整财报
FY 2023Revenue$530000.00▼ 98.53% YoY
202120222023
orgenesis inc. revenue · orgs revenue 2023
FY 2023Net Income-$55.4M▼ 271.82% YoY
202120222023
orgenesis inc. net income · orgs profit 2023
FY 2023EPS$-1.91▼ 223.73% YoY
202120222023
orgs eps · orgenesis inc. earnings per share 2023
TTM:Revenue: -$12.9MNet Income: -$43.9MEPS: $-2.80View income statement →

分析师评级与目标价

完整预测
SellBuy
Buy1 位分析师is orgs a buy · orgs analyst rating
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$0.49Current
$Avg Target
$High
orgs price target · orgs 12 month forecast

合计: 1 · 买入占比: 100.0%

股票表现

完整历史
1D+1.02%
1W+1.02%
1M+41.43%
3M-10.81%
YTD+230.00%
1Y-78.19%
5Y-99.03%

关于 Orgenesis Inc.

CEOVered Caplan
IPO DateMar 13, 2012
Employees146
CountryUS

Orgenesis Inc. is a global biotechnology firm dedicated to the field of cell and gene therapies. The company has engineered an innovative Point of Care (POCare) platform. This system incorporates a po…

what is orgenesis inc. · orgs stock overview · orgenesis inc. company profile · who is orgenesis inc. ceo · orgs OTC · orgenesis inc. headquarters · orgenesis inc. business segments

关于股票概览与关键数据

Orgenesis Inc.(ORGS)是 Biotechnology 行业的 Healthcare 类公司,于 Mar 13, 2012 在 OTC 上市。截至最近交易日,ORGS 股价为 $0.49,市值约为 $2.6M。过去12个月累计回报 -78.19%,年初至今回报 +230.00%。

根据 1 位华尔街分析师,Orgenesis Inc. 股票共识评级为Buy,12个月平均目标价为 $—。2023 财年 Orgenesis Inc. 营收 $530000.00,净利润 -$55.4M。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,Orgenesis Inc.(ORGS)股价为 $0.49,在 OTC 上市,52周区间为 $0.02 – $5.89。

ORGS 最新股价ORGS quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议